期刊文献+

阿立哌唑及氟哌啶醇治疗儿童青少年抽动障碍的开放性对照研究 被引量:7

下载PDF
导出
摘要 目的比较非典型抗精神病药物阿立哌唑与经典抗精神病药物氟哌啶醇治疗儿童青少年抽动障碍的疗效及耐受性。方法对48例符合《中国精神障碍分类与诊断标准(第3版)》(CCMD-3)抽动障碍诊断标准的儿童青少年抽动障碍患者按2:1比例随机分配入阿立哌唑或氟哌啶醇治疗组,分别治疗8周,治疗前后分别使用耶鲁抽动症严重程度量表(YGTSS)评定疗效,使用副反应量表(TESS)评定不良反应。结果两组患者治疗后的YGTSS总分均较治疗前下降,差异有统计学意义(P<0.001),但在治疗终点时两组间YGTSS总分差异无统计学意义(P>0.05);阿立哌唑组的睡眠过度、锥体外系症状及头痛三种不良反应发生率低于氟哌啶醇组(P<0.05)。结论阿立哌唑及氟哌啶醇对儿童青少年抽动障碍疗效相当,但阿立哌唑的耐受性优于氟哌啶醇。
出处 《四川精神卫生》 2013年第4期300-302,共3页 Sichuan Mental Health
  • 相关文献

参考文献9

  • 1Leckman JF. Tourette's syndrome[J].{H}LANCET,2002.1577-1586.
  • 2Rampello L,Alvano A,Battaglia G. Tic disorders from pathophysiology to treatment[J].{H}Journal of Neurology,2006.1-15.
  • 3Murphy TK,Mutch PJ,Reid JM. Open label aripiprazole in the treatment of youth with tic disorders[J].{H}Journal of Child And Adolescent Psychopharmacology,2009.441-447.
  • 4Gilbert DL,Batterson JR,Sethuraman G. Tic reduction with risperidone versus pimozide in a randomized double-blind crossover trial[J].{H}Journal of the American Academy of Child and Adolescent Psychiatry,2004.206-214.
  • 5Barzman D,Gernert B,Delbello M. Quetiapine for chronic motor tic disorder[J].{H}American Journal of Psychiatry,2004.1307.
  • 6梁月竹,周福春,郑毅,杨建虹,刘杰,王鹏,戚艳杰,陈旭,周玉明.阿立哌唑治疗抽动障碍的临床研究[J].精神医学杂志,2010,23(1):34-35. 被引量:17
  • 7刘智胜,陈燕惠,钟佑泉,邹丽萍,王华,孙丹,王大斌,廖建湘.阿立哌唑治疗Tourette综合多中心对照研究征患儿的[J].中华儿科杂志,2011,49(8):572-576. 被引量:18
  • 8任志斌,金卫东,王鹤秋.阿立哌唑与氟哌啶醇治疗儿童抽动障碍的对照研究[J].中国神经精神疾病杂志,2012,38(4):222-224. 被引量:22
  • 9Gibson AP,Crismon ML,Mican LM. Effectiveness and tolerability of aripiprazole in child and adolescent inpatients:a retrospective evaluation[J].{H}International Clinical Psychopharmacology,2007.101-105.

二级参考文献29

  • 1Murphy TK, Bengtson MA, Soto O, et al. Case series on the use of aripiprazole for Tourette syndrome. Int J Neuropsychopharmacol, 2005, 8: 489490.
  • 2Davies L, Stern JS, Agrawal N, et al. A case series of patients with Tourette' s syndrome in the United Kingdom treated with aripiprazole. Hum Psychopharmacol Clin Exp, 2006, 21: 447- 453.
  • 3Seo WS, Sung HM, Sea HS, et al. Aripiprazole treatment of children and adolescents with Tourette disorder or chronic tic disorder. J Child Adolesc Psychopharmacol, 2008, 18: 197-205.
  • 4Murphy TK, Mutch PJ, Reid JM, et al. Open label aripiprazole in the treatment of youth with tic disorders. J Child Adolesc Psychopharmacol, 2009, 19 : 441-447.
  • 5Lyon GJ, Samar S, Jummani R, et al. Aripiprazole in children and adolescents with Tourette's disorder: an open-label safety and tolerability study. J Child Adolesc Psychopharmacol, 2009, 19: 623-633.
  • 6American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th edition, text revision. Washington DC : American Psychiatric Association, 2000 : 108-113.
  • 7Leckman JF, Riddle MA, Hardin MT, et al. The Yale global tic severity scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry, 1989, 28: 566- 573.
  • 8Du YS, Li HF, Vance A, et al. Randomized double-blind muhicentre placebo-controlled clinical trial of the clonidine adhesive patch for the treatment of tic disorders. Aust N Z J Psychiatry, 2008, 42: 807-813.
  • 9Muller N. Tourette's syndrome : clinical features, pathophysiology, and therapeutic approaches. Dialogues Clin Neurosci, 2007, 9 : 161-171.
  • 10Kawohl W, Schneider F, Vernaleken I, et al. Aripiprazole in the pharmacotherapy of Gilles de la Tourette syndrome in adult patients. World J Biol Psychiatry, 2009, 10: 827-831.

共引文献46

同被引文献60

引证文献7

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部